Resistance Training impact on lean mass and Muscle Strength in Pancreatic Cancer

Resistance Training impact on lean mass and Muscle Strength in Pancreatic Cancer Cachexia: A Randomised Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202001818109834

Enrollment

Registered

2020-01-22

Start date

2017-06-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Musculoskeletal Diseases

Interventions

Resisted Training Program

Control Group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: resectable or non-resectable PC [stages I–IV]. adults [= 20 years of age]. compliance with international guidelines for cancer cachexia diagnosis, including: weight loss over the past 6 months > 5 percent. weight loss > 2 percent in patients with body mass index [BMI] of less than 20 kg / m2, evidence of sarcopenia with a weight loss of more than 2 percent.

Exclusion criteria

Exclusion criteria: any musculoskeletal disorders any neurological disorders the hematological capacity was severely impaired, uncontrolled hypertension, heart failure and unknown arrhythmia, severe renal impairment, diminished ability to stand or walk, any other comorbidities that may hinder exercise.

Design outcomes

Primary

Measure	Time frame
Lean body mass ;muscle strength	—

Secondary

Measure	Time frame
Physical performance	—

Countries

Egypt

Contacts

Public ContactASHWAG ALSHARIDAH

Assistant Professor

Ashwagalshrida@gmail.com0096650701879

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026